MTOR and malignant colon neoplasm: The second analyzed inhibition target of the PI3K/Akt/mTOR pathway was PI3K in HT29, HCT116 (Supplementary Figure S4A-S4D), and SW480 (Supplementary Figure S4E-S4H) colon cancer cells.